BPC:CSE, The Precision Peptide Company Inc.
Why BPC stock rose on November 17
The Precision Peptide Company Inc. rose 17.4%
on Tuesday, November 17, 2026, on 200,000 shares.
The headline around the move:
BPC stock overview
The Precision Peptide Company Inc. (BPC:CSE) closed at $0.225 on November 19, 2026,
down 6.25% on the day.
The stock trades 61.2% below its 52-week high of $0.580
and 28.6% above its 52-week low of $0.175.
Over the past year, it lost 42.3%.
The Precision Peptide Company Inc. is part of the Consumer Staples sector.
Key figures
- Price
- $0.225
- Day change
- -6.25%
- Volume
- 32,236
- Average volume
- 129,648
- Market cap
- 12M+
- 52-week range
- $0.175 – $0.580
- 50-day average
- $0.343
- 200-day average
- $0.404
Price action over the past year
In 252 trading sessions since November 19, 2025, BPC closed higher on 98 days (39%).
Its best day was February 13, 2026 (+29.27%) and its worst was December 10, 2025 (-16.67%).
The stock moved 10% or more in a single session 27 times.
Recent signals
BPC news
-
Nov 19, 2026:
The Precision Peptide Company Wins TikTok Shop Approval as Platform Tightens Peptide Rules, Putting U.S.-Made Peptide Products in Front of 53 Million American Buyers
-
Nov 17, 2026:
The Precision Peptide Company Launches Free Shipping to All 50 States on Its U.S.-Made Over-the-Counter Range
-
Nov 11, 2026:
The Precision Peptide Company Highlights a Landmark Year and Outlines 2027 Growth Priorities
-
Nov 5, 2026:
The Precision Peptide Company Moves Early on New Federal Peptide Policy, Adding All Six Covered Peptides to Its Prescription Platform
-
Nov 3, 2026:
The Precision Peptide Company's Needle-Free First Strategy Already in Place as HHS Draft Policy Recognizes Non-Injectable Routes for Leading Peptides
-
Oct 29, 2026:
The Precision Peptide Company Quadruples U.S. Telehealth Formulary to 16 Prescription Therapies Across Seven Therapy Areas
-
Oct 28, 2026:
The Precision Peptide Company Highlights 30 Years of Peptide Science Behind Its Product Platform
-
Oct 22, 2026:
The Precision Peptide Company Locks In Exclusive Manufacturing Rights Across Its Needle-Free Line
About The Precision Peptide Company Inc.
Pangea Wellness Inc. is a North American manufacturer specializing in clean-label foods and innovative wellness products. Through its subsidiary Amino Innovations, the Company offers advanced, needle-free peptide therapies that support recovery, cognitive function, and overall health.
Similar stocks
Find more stocks like BPC with the
Spikes,
Gaps,
Breakouts and
Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.